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Dear Editor,
We would like to thank Ji et al. [1] for
their comments regarding our
recently published study [2]. The
authors raised two very interesting
and relevant points of concern.
First, they point out that we might
have missed the initial peak in TNF-a
expression shortly after LPS infusion
and therefore cannot conclude that
neither immediate nor late ﬂuid could
prevent systemic inﬂammatory acti-
vation. However, although we may
have missed the peak expression, we
could still detect increased TNF-a
levels at the end of our protocol group
which evidently indicates that neither
immediate nor late ﬂuid resuscitation
could completely prevent systemic
inﬂammatory activation. Further-
more, plasma TNF-a may not
accurately reﬂect TNF-a kinetics in
tissue. For instance, Detmer et al. [3]
found that TNF-a increased until
360 min after LPS exposure in
smooth muscle cells. The kinetics of
TNF-a release may also been modi-
ﬁed by interaction of TNF-a with
other cytokines. Andersson et al. [4]
found a reciprocal functional rela-
tionship between cytokines with
HMG-1 extending and amplifying the
secretion of TNF-a. Thus, if anything,
the point raised by Ji et al. does not
preclude our conclusion. Nonetheless,
we must acknowledge that the main
aim of our study was not to investi-
gate the whole picture of the LPS-
induced cytokine response spectrum,
but to investigate the role of LPS-
induced hypotension and renal hypo-
perfusion in the development of renal
microcirculatory dysfunction and
systemic and renal inﬂammatory
activation. The method we used ﬁts
this goal.
Second, Ji et al. raised concerns
regarding the relatively small sample
size. This might be a valid point here.
However, although we can not
exclude a lack of power, we believe
that increasing the sample size would
not show a different result with
respect to the very similar TNF-a
plasma levels in the immediately and
delayed resuscitated groups. The
authors also pointed out that there
was a clerical error in the abstract of
the article. For this we would like to
apologize.
Finally, the authors state that the
data presented in our study should be
interpreted with some caution. Of
course, as should the data presented
in every study. Furthermore, the
authors state that more research is
needed. Again, we agree. Although
we could explore the role of renal
hypoperfusion in the development of
renal microcirculatory failure, appli-
cation of immediate ﬂuid
resuscitation is clinically impossible.
Hence, future research could focus on
developing therapeutic strategies
protecting the renal microcirculation
in endotoxemia, hemorrhage, ische-
mia/reperfusion injury, and other
scenarios in which the kidney might
suffer from hypoperfusion and
inﬂammation.
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